Hindustan Bio Sciences Q2 Results
- BSE: 532041
- NSE: -
- ISIN: INE597C01021
- Sector: Biotechnology & Drugs
BSE
7.58
-0.39 (-4.89%)
-0.39 (-4.89%)Volume736.00
Updated: Tue 10 Mar, 2026 | 15:15:00
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Hindustan Bio Sciences Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 0.07 | 0.32 | -79.10% | 0.05 | 34.81% |
| Depreciation/ Amortization | 0.00 | 0.00 | 0.00% | 0.00 | 1200.00% |
| Operating Income | -0.07 | 0.00 | 0.00% | -0.05 | 34.81% |
| Net Income | -0.06 | 0.01 | 0.00% | -0.05 | 16.53% |
| Other Operating Expenses Total | 0.01 | 0.06 | -78.64% | 0.02 | -15.09% |
| Net Income Before Taxes | -0.06 | 0.01 | 0.00% | -0.05 | 16.53% |
| Total Revenue | 0.00 | 0.32 | 0.00% | 0.00 | 0.00% |
| Selling/ General/ Admin Expenses Total | 0.05 | 0.05 | 9.01% | 0.03 | 48.06% |
| Diluted Normalized EPS | -0.06 | 0.01 | 0.00% | -0.05 | 20.00% |